Taku Tsukamoto

6PUBLICATIONS
20CO-AUTHORS
Medical mycologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 16, 2026
Distinct Clinical Features of Multiple Myeloma With t(11;14): A Post Hoc Analysis of JSH-MM-15 Study.

|Aug 24, 2026
Cellular and molecular impacts of CELMoDs and IMiD on the induction of myeloid-derived suppressor cells by myeloma cells.

|Jan 08, 2025
The real-world efficacy and safety of frontline therapy of obinutuzumab plus bendamustine for untreated high-tumor-burden follicular lymphoma.

Hiroaki Nagata, Taku Tsukamoto, Tsutomu Kobayashi

|Dec 05, 2023
miR-17-92 cluster-BTG2 axis regulates B-cell receptor signaling in mantle cell lymphoma.

Yuka Kawaji-Kanayama, Taku Tsukamoto, Masakazu Nakano

|Oct 16, 2023
Triple targeting of RSK, AKT, and S6K as pivotal downstream effectors of PDPK1 by TAS0612 in B-cell lymphomas.

Yoko Katsuragawa-Taminishi, Shinsuke Mizutani, Yuka Kawaji-Kanayama

Pageof 1

Frequent Collaborators

5 joint publications

Junya Kuroda

2 joint publications

Yuji Shimura

1 joint publications

Masakazu Nakano

1 joint publications

Akio Onishi